Renaud, C.O.; Ziros, P.G.; Mathias, A.; Pot, C.; Sykiotis, G.P.
Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants 2022, 11, 1015.
https://doi.org/10.3390/antiox11051015
AMA Style
Renaud CO, Ziros PG, Mathias A, Pot C, Sykiotis GP.
Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants. 2022; 11(5):1015.
https://doi.org/10.3390/antiox11051015
Chicago/Turabian Style
Renaud, Cédric O., Panos G. Ziros, Amandine Mathias, Caroline Pot, and Gerasimos P. Sykiotis.
2022. "Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study" Antioxidants 11, no. 5: 1015.
https://doi.org/10.3390/antiox11051015
APA Style
Renaud, C. O., Ziros, P. G., Mathias, A., Pot, C., & Sykiotis, G. P.
(2022). Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study. Antioxidants, 11(5), 1015.
https://doi.org/10.3390/antiox11051015